Home

Register

Agenda

Media Partners

Exhibition

Venue

Accommodation

Short Courses

Speaker Biographies

Edith Chan, Head of Molecular Design, Chematica
Dr. Chan is Head of Molecular Design at Chematica.
Edith has 13 years pharmaceutical experiences in the area of Molecular modeling, Cheminformatics, Structure-based drug design and Combinatory chemistry.
At present in Inpharmatica, her group is involved in developing chemoinformatics databases, molecular modeling, and scientific programming. She has previously worked in Aventis for 6 year, which involved all spectrum of drug discovery programs.

Darren Fayne, Senior Research Fellow in Biochemistry Trinity College Dublin
Dr Darren Fayne holds a PhD from Dublin City University where the main focus of his work was the molecular modelling of calixarene inclusion complexes. He worked for 2 years at Solvay Pharmaceuticals in Hannover, Germany as a molecular designer from March 2003. While with the Computer-Aided Drug Design Group he focused on two main therapeutic areas of research: Cardiovascular disease and Gastroenterology (IBS/IBD). In July 2005 Dr Fayne returned home and joined the Molecular Design Group in Trinity College Dublin as a senior research fellow. His research focus is the rational computational design of novel small molecular modulators of key proteins involved in specific diseases.

Jens Hartung, Professor of Organic Chemistry, TU Kaiserslautern
Jens Hartung (born 1961 in Offenbach, Germany) obtained his Ph.D. degree (TU Darmstadt, 1990) working on a project dealing with photochemical reactions of organocobalt compounds under the guidance of B. Giese. Following a post-doctoral appointment with K.B. Sharpless (1990–1991), he joined the cardiovascular division of the Hoechst AG (Frankfurt a.M., 1992–1993; today: Sanofi-Aventis). In 1994, he moved to the University of Würzburg and in order to pursue the chemistry of oxygen-centered radicals and transition metal-catalyzed oxidation. In 2002, he accepted a permanent position as head of the organic chemistry division at the TU Kaiserslautern.

Alison Hulme, Lecturer in Organic Chemistry, University of Edinburgh
Dr Alison N. Hulme is a Senior Lecturer at the University of Edinburgh and in 2006 she held a Scottish Executive / RSE Research Support Fellowship in "Chemical Biology Approaches to Tagging and Imaging in Biological Systems".
Her group has worked in the field of natural product synthesis for more than 10 years, and has recently applied this expertise to the design of fluorescent, luminescent, biotinylated and "spin-labelled" molecular probes.

Alex Kiselyov, Executive VP of R&D, ChemDiv, Inc.
Dr. Kiselyov’s main interest is in the area of lead discovery, with a focus on medicinal chemistry, chemoinformatics, and HTS. His main interests include development of specific and dual small molecule modulators for kinase targets, chemokine receptors and Hh/Wnt signaling cascades. Most recently, Dr. Kiselyov was Assistant Vice President of Chemistry for ImClone Systems, Inc. Prior to ImClone, Dr. Kiselyov directed oncology team and combinatorial chemistry efforts at Amgen, Inc. Dr. Kiselyov did his doctoral work at Georgia State University and postdoctoral study at Columbia University and the University of Chicago.
Dr. Kiselyov has over 13 years of industrial experience in medicinal and organic chemistry and has authored more than 100 publications in the areas of synthetic and medicinal chemistry including oncology. His work has resulted in 26 patents and patent applications.

Hugo Kubinyi, Professor of Pharmaceutical Chemistry, University of Heidelberg
Hugo Kubinyi is a medicinal chemist with 35 years of industrial experience in Knoll and BASF AG, Ludwigshafen. Since 1987, until his retirement in summer 2001, he was responsible for the Molecular Modelling, X-ray Crystallography and Drug Design group of BASF, since early 1998 also for Combinatorial Chemistry in the Life Sciences.
He is Professor of Pharmaceutical Chemistry at the University of Heidelberg, former Chair of The QSAR and Modelling Society and IUPAC Fellow. In 2006 he received the ACS Herman Skolnik Award in Chemoinformatics. From his scientific work resulted more than 100 publications and seven books on QSAR, Drug Design, Chemogenomics, and Drug Discovery Technologies.

Rodolfo Lavilla, Professor of Chemistry and Molecular Pharmacology, Institute for Research in Biomedicine, Barcelona Science Park
1982 B. Sc. University of Barcelona.
1983 M.Sc. University of Barcelona.
1987 Ph. D. University of Barcelona Advisor Prof. M. Alvarez.
1988-1990Post-Doctoral Fellow. Department of Chemistry and Biochemistry. University of California, San Diego. (Advisor Prof. E. Wenkert).
(1991- ) Professor. Organic Chemistry. Faculty of Pharmacy. University of Barcelona.
Advisor of 5 Ph. D. theses and over 20 Master theses.
Over 45 papers published in the fields of heterocyclic chemistry, multicomponent reactions and natural product synthesis.
Several invited lectures in Congress and Chemistry Departments in Europe, USA and Asia.
Research Projects:
“Natural Products Synthesis”. (Indole Alkaloids,)
“Heterocyclic Chemistry. New Reactivity of Azine derivatives”
“Multicomponent Reactions based on Pyridine derivatives”
“Synthesis of scaffolds for lead finding” (in collaboration with pharmaceutical companies).

Svetlana Morozkina, Assistant Professor, Saint-Petersburg State University
Svetlana Morozkina was born in 1975, graduated in 1997 from Department of Organic Chemistry at Saint-Petersburg State University. She subsequently obtained a Ph.D. at Department of Organic Chemistry, Saint-Petersburg State University in 2000. After this she was granted by Russia Government for Post-Doc position for 2001-2004 at Saint-Petersburg State University. In 2004, Dr Svetlana Morozkina was appointed an Assistant Professor at the Natural Products Chemistry Department. The field of her group research interests is synthesis, investigation of molecular structure and biological activity of steroid estrogen analogues, including the development of optical pure steroid estrogen analogue’s synthesis.

Thomas Müller, Professor of Organic Chemistry, Heinrich-Heine-Universität Düsseldorf
Born in 1964 in Würzburg, Germany; Studies of chemistry at Ludwig-Maximilians-Universität (LMU) München (1984-1989); , Ph. D. at LMU München (1992); Postdoc at Standord University with Prof. Barry M. Trost (1993-1994); Independent research at Technische Universität Darmstadt (1995-1996) and at LMU München (1997-1999); Habilitation (2000); Acting professor at Universität Stuttgart (1999-2000); Privatdozent at LMU München (2000-2001); , Professor of Organic Chemistry at Ruprecht-Karls-Universität Heidelberg (2002-2006); Since 10/2006 Chair of Organic Chemistry at Heinrich-Heine-Universität Düsseldorf.

Zhonghua Pei, Research Investigator, Abbott Laboratories
Zhonghua received his B.S. degree from University of Science and Technology of China, Hefei, Anhui. He then moved to Rensselaer Polytechnic Institute in the United States and obtained a master’s degree in chemistry. He received his Ph. D. degree in organic chemistry from Massachusetts Institute of Technology in 1997, and then he joined Abbott Laboratories where he has been since. His research interest has been medicinal chemistry, especially in immunological and metabolic diseases. Dr. Pei has published extensively in peer-reviewed journals and holds numerous patents in these areas.

Valery Petrenko, Professor, Auburn University
Valery Petrenko graduated from Moscow State University (1972), and received the PhD degree from the Institute of Organic Chemistry (1976), and D.Sc. degree from Moscow State University (1988), Russia. He worked as Junior and Senior Scientist (1977-1982), Laboratory Head (1982-1985), Scientific Deputy Director (1985-1989), Director of Institute, Scientific Deputy General Director and Professor (1989-1993) in “Vector”, Novosibirsk, Russia. In 1992 he received Honor Rank of Professor in Molecular Biology. In 1993 he joined the faculty of University of Missouri-Columbia as Visiting and Research Professor, and in 2000—Auburn University as Professor. He is recipient (PI) of ARO, DARPA and NIH grants, and the Pfizer Animal Health Award for Research Excellence (2006).

Vladimir Potemkin, Professor/Head, Chelyabinsk State University
Date of Birth 1962 , 1985 Graduated with honour from Chelybinsk State University. , 1987 Scientist in Chelybinsk State University. , 1989 Senior Scientist. , 1998 Ph.D. degree, Senior Lecturer , 2000 Head of Laboratory of Theoretical Problems of Organic Chemistry , 2006 Dean of Chemical Department

Herman Verheij, Department Head, Computational Chemistry, Pyxis Discovery
Herman Verheij received his PhD in Physical Organic Chemistry in 1997 at the University of Amsterdam. After holding a Post-doc position for 2 years in Wageningen (The Netherlands), he joined the Dutch Chemistry Supplier Specs, where he held a job as Manager of the Department of Cheminformatics and Screening Collaborations.
In 2003 Dr. Verheij joined Pyxis Discovery, a Dutch Drug Discovery company, where he is responsible for both (computational) Chemistry and Screening Projects. He has published over 20 papers in international peer-reviewed scientific journals, His most recent publication being “Verheij, H.J., ‘Leadlikeness and Structural Diversity of Synthetic Screening Libraries’, Molecular Diversity 10 (2006), 3, 377-388.”

Malcolm Walkinshaw, Professor of Structural Biochemistry, University of Edinburgh
Malcolm Walkinshaw obtained both his BSc (1973) and PhD (1976) degrees from the Chemistry Department at the University of Edinburgh. After leading a structure-based drug design group in Sandoz in Switzerland for ten years, he took up the Chair of Structural Biochemistry in 1995 at the University of Edinburgh. He has published over 200 papers on molecular recognition, protein structure and drug discovery. His lab currently consists of 20 research fellows, PhD students and support staff using crystallographic, biophysical and computational approaches to study protein-ligand interactions.

Nicholas Westwood, Lecturer, University of St Andrews
Nick Westwood completed his PhD education at Oxford (Prof. Chris Schofield) before carry out 6 years post-doctoral research in the US working with Professors Philip Magnus FRS, Matthew Shair and Tim Mitchison FRS at Texas and Harvard. He moved to the School of Chemistry at the University of St Andrews in 2001 where he has established a research program at the chemistry-biology interface (CBI). Whilst his group focuses on synthetic aspects of the chemical genetic approach, he addresses a series of biological questions in cancer and infectious diseases through excellent collaborations. This seminar will cover recent synthetic aspects of research at the CBI from the Westwood group.

Jieping Zhu, Research Director, Institut de Chimie des Substances Naturelles CNRS
Jieping Zhu, Director of Research at CNRS, obtained his Ph.D. degree in 1991 from Université Paris XI under the supervision of Professor H.-P. Husson and Professor J.-C Quirion. After one and half year post-doctoral stay with Professor Sir D. H. R. Barton at Texas A & M University, he joined the Institut de Chimie des Substances Naturelles, CNRS, France in December 1992. His research is focused on the development of novel synthetic methods, their applications in synthesis of bioactive natural products and the design of novel multicomponent reactions. He was honored a CNRS bronze medal (1996), a French Chemical Society SFC-Across award (1999), an AstraZeneca Award in Organic Chemistry (2002), a Japan Society for Promotion of Science (JSPS) research fellow (2002) and Liebig Lectureship of the German Chemical Society (2004).